The MARVIN Chatbots to Provide Information for Different Health Conditions

This research is a continuation of a usability study with the MARVIN chatbot. The investigators aim to adapt the MARVIN chatbot to open it to other health domains (e.g. breast cancer) and populations (e.g. pharmacists). Therefore, this protocol constitutes a master research protocol that will englobe different research projects with individual chatbots. The investigators adopt an adaptive platform trial design, which will allow flexibility in handling multiple interventions adapted to different populations while retaining the characteristics of a platform trial design allowing early withdrawal

Trial Details

NCT ID
NCT05789901
Phase
NA
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • MARVIN
  • MARVIN-Pharma
  • MARVINA
  • MARVIN-CHAMP
Locations (sample)
  • Montreal, Quebec, Canada|45.50884,-73.58781
  • Montreal, Quebec, Canada|45.50884,-73.58781

Key Eligibility Criteria

  • being 14 years or older;
  • being fluent in English and/or French;
  • being able to understand the requirements of study participation and provide informed consent during the duration of the study;
  • having access to a smartphone, tablet, or computer at home/at workplace;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →